The Indian pharmaceutical industry has the potential to deliver 100 new drugs for global markets by 2047, driven by enhanced research and development (R&D) efforts, Zydus Lifesciences Chairman Pankaj R Patel said on Friday.Speaking at an event, Patel emphasized the critical role of innovation, capability building, and a focus on societal benefit in achieving this milestone.”I believe India can deliver 100 new chemical entities or new drugs to the world by 2047 and off course, it will require effort,” Patel said while speaking at the SOUL leadership conclave 2025.As per a PTI report, he termed it a myth that drug discovery requires a billion dollars while emphasising that it is possible with the right approach.Patel also asserted that the people working in an organisation are the most valuable resource and pitched for an environment where people love to work.He also emphasised the evolving nature of leadership, highlighting the importance of humility, vision, and a global perspective.Patel also shared experiences, including the Prime Minister’s proactive response to COVID-19 and the organisation’s rapid vaccine development.He noted that it is important to embrace challenges, celebrating failures, and fostering an environment where people thrive.Read also: Zydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in USSpeaking at the sidelines of the event, Piramal Group Chairman Ajay Piramal noted that the country is moving ahead in the right direction.”I think this is the best time to be young. I would say that because where India is placed, is better placed today than it has been in my whole career, and the way that we are as an economy, then as the sort of leadership that we have, and we are seeing that we are standing out in the world,” he notedRead also: Zydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis